Any idea if this is normal or not for dutasteride early treatment.
    9/26/2026

    From the encyclopedia
    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 5 months
    💧 Minoxidil (topical)
    the tone is 😞 negative.

    Other terms

    The user is experiencing worsening hair loss despite using dutasteride and cannot use minoxidil due to scalp sensitivity. They are advised to wait longer for potential regrowth, as shedding is common early in treatment.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Minoxidil: a comprehensive review

      16 citations , June 2021 in “Journal of Dermatological Treatment”
      This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.

      research An overview of female pattern hair loss

      2 citations , June 2011 in “Expert Review of Dermatology”
      This review discusses the characteristics and management options for female pattern hair loss, highlighting the unclear role of androgens and the psychosocial impact, and reports no new clinical results.

      research Male and female pattern hair loss

      June 2025 in “Australian Prescriber”
      In this study, the authors highlighted treatments for androgenetic alopecia, noting that combination therapies with drugs like minoxidil and antiandrogens often require at least 6 months for clinical improvement, while also emphasizing the value of patient counseling for informed treatment choices.

      research Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-α reductase inhibitors in androgenetic alopecia management: A systematic review

      June 2024 in “Journal of Drug Delivery Science and Technology”
      This review highlights that nanocarrier-based formulations, using both synthetic drugs and natural components, show promise in overcoming the limitations of current androgenetic alopecia treatments with modified release profiles and enhanced drug delivery, though clinical trials remain limited.

      research Interventions for female pattern hair loss

      35 citations , May 2012 in “Cochrane Database of Systematic Reviews”
      This review found evidence supporting the effectiveness and safety of topical minoxidil for treating female pattern hair loss, though many included studies were at high risk of bias.